pfizer glp-1 news Companies are racing to improve your experience Pfizer is pulling back the

Second, exenatide tends to cause more weight loss and lower glucose control than liraglutide, which may result in a higher risk of bone fractures (1

In contrast to RCTs, retrospective observational studies offer the benefit of capturing extensive patient data in real-world settings

Data are presented on a log scale

to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction or non-fatal stroke) in adults with type 2 diabetes and established cardiovascular disease

Are You a Good Candidate for Post-Weight Loss Surgery

AWARD-6 is a randomized, open, parallel-grouped, multicenter, phase 3, non-inferiority study comparing the safety and efficacy of weekly DUL and daily LIR in patients with uncontrolled T2DM treated with metformin